221 POSTER A novel inhibitor of phosphoinositide 3-kinase for the treatment of cancer
K R Auger(Providence College), Dashyant Dhanak(Wilmington University), Steven D. Knight(GlaxoSmithKline (United States)), Robert A. Copeland(Unknown), Peter J. Tummino(Intarcia Therapeutics (United States)), Jeffrey R. Jackson(New Frontier), Melody Diamond(South College), Liang Luo(Chinese Academy of Fishery Sciences), Glenn Van Aller(GlaxoSmithKline (United States)), David Sutton(South College)
Cited by 5
Related Papers
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
|Journal of Biological Chemistry|1998|3k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848